Loading…
Ramdevbaba Solvent (RBS)₹82.800.00%Edible Oil
In the Mar 2026 quarter (consolidated), Ramdevbaba Solvent reported sales of ₹438 Cr, down 16.9% from Mar 2025, and net profit of ₹4.99 Cr, down 28.6% year on year. For the year to Mar 2026, sales were ₹823 Cr and net profit ₹10.99 Cr.
Company filings, consolidated accounts; latest reported quarter Mar 2026
| Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 346 | 295 | 392 | 402 | 527 | 386 | 438 |
| Expenses | 337 | 284 | 380 | 389 | 516 | 373 | 427 |
| Operating Profit | 10.02 | 12.02 | 13.04 | 14.04 | 12.04 | 14.04 | 12.03 |
| OPM % | 3.0% | 4.1% | 3.3% | 3.4% | 2.3% | 3.6% | 2.7% |
| Other Income | 3.99 | 1.99 | 4.99 | 2.99 | 3.99 | 2.99 | 2.99 |
| Interest | 2.99 | 4.99 | 4.99 | 3.99 | 3.99 | 4.99 | 3.99 |
| Depreciation | 0.99 | 1.99 | 1.99 | 1.99 | 1.99 | 2.99 | 2.99 |
| Profit before tax | 10.02 | 7.02 | 10.01 | 11.02 | 9.01 | 9.02 | 7.01 |
| Tax % | 25.9% | 24.9% | 27.9% | 25.9% | 24.9% | 31.9% | 28.9% |
| Net Profit | 7.99 | 5.99 | 7.99 | 7.99 | 6.99 | 5.99 | 4.99 |
| EPS (Rs) | 167.02 | 10.97 | 4.62 | 3.65 | 3.05 | 2.91 | 2.11 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales | 416 | 576 | 698 | 686 | 929 | 823 |
| Expenses | 404 | 560 | 681 | 662 | 905 | 800 |
| Operating Profit | 13.03 | 17.03 | 19.04 | 25.07 | 26.09 | 26.06 |
| OPM % | 3.2% | 3.0% | 2.7% | 3.7% | 2.8% | 3.1% |
| Other Income | 2.99 | 1.99 | 8.98 | 6.98 | 6.99 | 5.99 |
| Interest | 3.99 | 4.99 | 5.99 | 9.99 | 7.99 | 9.99 |
| Depreciation | 3.99 | 4.99 | 1.99 | 3.99 | 4.99 | 4.99 |
| Profit before tax | 9.02 | 9.01 | 19.03 | 18.02 | 20.03 | 16.02 |
| Tax % | 27.9% | 27.9% | 23.9% | 25.9% | 24.9% | 30.9% |
| Exceptional items | 0.02 | 0.00 | 0.12 | 0.00 | 0.00 | 0.00 |
| Net Profit | 5.99 | 6.99 | 14.98 | 12.99 | 14.99 | 10.99 |
| EPS (Rs) | 134.48 | 143.62 | 320.31 | 8.03 | 6.57 | 5.01 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 5.00 | 5.00 | 5.00 | 15.98 | 23.04 | 23.02 |
| Reserves | 23.91 | 29.89 | 42.86 | 56.80 | 128 | 140 |
| Borrowings | 45.05 | 65.05 | 99.10 | 192 | 268 | 360 |
| Other Liabilities | 27.87 | 31.84 | 43.80 | 63.69 | 63.75 | 76.63 |
| Total Liabilities | 101 | 131 | 191 | 329 | 482 | 598 |
| Fixed Assets | 38.91 | 39.91 | 61.80 | 98.69 | 103 | 125 |
| CWIP | 0.00 | 12.03 | 28.07 | 69.14 | 189 | 192 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 61.92 | 78.84 | 101 | 161 | 191 | 282 |
| Inventories | 36.93 | 34.91 | 46.88 | 60.91 | 77.80 | 137 |
| Trade receivables | 18.94 | 27.91 | 38.83 | 40.85 | 31.87 | 32.86 |
| Cash & equivalents | 1.01 | 0.00 | 0.00 | 8.01 | 4.01 | 1.01 |
| Total Assets | 101 | 131 | 191 | 329 | 482 | 598 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from operating activity | 11.98 | 2.99 | 10.98 | −22.97 | −0.99 | −55.93 |
| Cash from investing activity | −13.01 | −18.01 | −39.04 | −83.04 | −128 | −29.99 |
| Cash from financing activity | 1.99 | 15.01 | 27.99 | 113 | 125 | 82.01 |
| Net cash flow | 0.99 | −0.99 | 0.00 | 6.98 | −2.99 | −2.99 |
| Capex | 13.29 | 18.21 | 39.45 | 82.67 | 128 | 29.70 |
| Free cash flow | −2.01 | −16.01 | −29.03 | −105 | −129 | −86.14 |
| CFO / OP % | 96.1% | 23.1% | 69.1% | −74.0% | 7.0% | −204.0% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor days | 17 | 19 | 21 | 23 | 14 | 16 |
| Inventory days | 39 | 26 | 29 | 40 | 36 | 73 |
| Days payable | 21 | 17 | 20 | 22 | 15 | 19 |
| Cash conversion cycle | 36 | 29 | 32 | 42 | 35 | 71 |
| Working capital days | 4 | 8 | 2 | 14 | 24 | 29 |
| ROCE % | — | 17.0% | 20.0% | 13.0% | 8.0% | 5.0% |
For the Mar 2026 quarter, Ramdevbaba Solvent reported sales of ₹438 Cr, down 16.9% year on year and net profit of ₹4.99 Cr, down 28.6% year on year. The operating margin was 2.7%.
Ramdevbaba Solvent's sales for the year to Mar 2026 were ₹823 Cr.
Net profit for the year to Mar 2026 was ₹10.99 Cr. Earnings per share over the same trailing period were ₹5.01.
Ramdevbaba Solvent reported borrowings of ₹360 Cr at Mar 2026, against cash and equivalents of ₹1.01 Cr.
Cash from operations was −₹55.93 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹86.14 Cr.